2019
DOI: 10.1208/s12249-019-1512-y
|View full text |Cite
|
Sign up to set email alerts
|

New Perspective Enteric-Coated Tablet Dosage Form for Oral Administration of Ceftriaxone: In Vitro and In Vivo Assessments

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
16
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(16 citation statements)
references
References 34 publications
0
16
0
Order By: Relevance
“…All bands appeared very close to the reported data. 25 Characteristic bands of ceftriaxone appeared in the same position in the PM. Cefepime showed main characteristic bands at 2935 cm −1 , 1773.29 cm-1 , and 1655 cm −1 corresponding to O-H stretching, β-lactam C=O stretching, and amide C=O, respectively.…”
Section: Characterizations Of Tdnmentioning
confidence: 94%
See 2 more Smart Citations
“…All bands appeared very close to the reported data. 25 Characteristic bands of ceftriaxone appeared in the same position in the PM. Cefepime showed main characteristic bands at 2935 cm −1 , 1773.29 cm-1 , and 1655 cm −1 corresponding to O-H stretching, β-lactam C=O stretching, and amide C=O, respectively.…”
Section: Characterizations Of Tdnmentioning
confidence: 94%
“…Figure 3C shows the DSC thermograms of the ceftriaxone system. The drug produced its melting point endothermic peak at 181°C, 25 thermogram of the PM. Cefepime produced its characteristic peak at 185°C which is corresponding to its melting point.…”
Section: Characterizations Of Tdnmentioning
confidence: 99%
See 1 more Smart Citation
“…A very neoteric endeavor was recently published by the authors in which a new perspective enteric-coated tablet dosage form for oral administration of CTX was maneuvered. 3 The promising results of this survey made the authors more eager to dedicate the present study with an epochal strategy that could accomplish the oral march of CTX with better bioavailability and sustained release.…”
Section: Introductionmentioning
confidence: 92%
“…The oral absolute bioavailability (F) was calculated from the relationship = (oral AUC 0-∞ /IV AUC 0-∞ ), where IV AUC 0-∞ is for intravenously administered CTX. 3 The mean residence time (MRT) was calculated as the ratio of area under the first moment curve (AUMC 0-∞ ) to (AUC 0-∞ ) where the mean absorption time (MAT) was the difference between oral MRT and that after IV one. 3 K abs is the firstorder absorption rate constant, and it was calculated as 1/ MAT; while the absorption half-life (T 1/2abs ) was calculated as 0.693/K abs .…”
Section: Pharmacokinetic Data Analysismentioning
confidence: 99%